Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on November 4, 2020
October 29 2020 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its third-quarter 2020 financial results after the
close of the U.S. financial markets on Wednesday, November 4, 2020.
The company hosted a conference call on October 13, 2020, in
conjunction with reporting preliminary third-quarter net sales. A
replay of that call is available on Flexion’s corporate website:
https://ir.flexiontherapeutics.com/events-and-presentations.
About Flexion TherapeuticsFlexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, the most common form of
arthritis. The ompany's core values are focus, ingenuity, tenacity,
transparency and fun. Visit flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications &
Investor RelationsT: 781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024
